"Where Everyone Has an MBA"
Tel: (612) 246-4616
Frequently Asked Questions
- Frequently Asked Questions
- User Testimonials
Array Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Array Biopharma Inc
Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Array Biopharma, Inc.
- Nov 22nd, 2017 2:33 pm
ARRY SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Array BioPharma Inc.
- Nov 22nd, 2017 10:43 am
Array BioPharma To Present At The 2017 Piper Jaffray Healthcare Conference
- Nov 22nd, 2017 8:00 am
ARRAY BIOPHARMA LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Array Biopharma, Inc. To Contact The Firm
- Nov 21st, 2017 4:25 pm
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Array Biopharma, Inc. - ARRY
- Nov 21st, 2017 2:59 pm
SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Array Biopharma, Inc. (ARRY)
- Nov 21st, 2017 1:18 pm
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint on Behalf of Array Biopharma Inc. Shareholders and Lead Plaintiff Deadline of January 22, 2018 – ARRY
- Nov 21st, 2017 9:40 am
Is the Options Market Predicting a Spike in Array BioPharma (ARRY) Stock?
- Nov 21st, 2017 6:43 am
See what the IHS Markit Score report has to say about Array Biopharma Inc.
- Nov 21st, 2017 6:02 am
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Array BioPharma Inc.
- Nov 20th, 2017 8:33 am
Array BioPharma, Inc. breached its 50 day moving average in a Bullish Manner : ARRY-US : November 20, 2017
- Nov 20th, 2017 5:26 am
Array BioPharma Announces Private Exchange of $107 Million of its 3.00% Convertible Senior Notes due 2020 for its 2.625% Convertible Senior Notes due 2024 and Shares of its Common Stock
- Nov 16th, 2017 3:54 pm
ETFs with exposure to Array BioPharma, Inc. : November 16, 2017
- Nov 16th, 2017 9:10 am
Today’s Research Reports on Trending Tickers: Array BioPharma and Intrexon Corporation
- Nov 15th, 2017 6:20 am
Array BioPharma Reports Initial Results From Novel Immunotherapy Combination At The Society For Immunotherapy Of Cancer (SITC) 32nd Annual Meeting
- Nov 13th, 2017 6:00 am
Corporate News Blog – Keryx Announces FDA Approval of Auryxia for Treatment of Iron Deficiency Anemia Patients with Chronic Kidney Disease
- Nov 9th, 2017 5:00 am
Frequently Asked Questions
Terms and Conditions
Copyright © 2017 VentureLine
Website developed by Digital Solutions